$LGVN 3 SEC Filings

Filed On	Filing
25 Aug 2026	Form 3: Jhaveri Nirav S., Chief Financial Officer Holds 0 shares of Class A Common Stock
21 Jul 2026	Form 3: Washburn Marie, Chief Financial Officer Holds 101,030 shares of Class A Common Stock
14 Jul 2026	Form 3: Desai Arjun Jj, Director Holds 0 shares of Class A Common Stock
13 Jul 2026	Form 3: Cann Leah Rush, Director Holds 0 shares of Class A Common Stock
13 Jul 2026	Form 3: Ascheim Deborah, Director Holds 0 shares of Class A Common Stock
13 Mar 2026	Form 3: Willard Stephen H, Chief Executive Officer Holds 0 shares of Class A Common Stock
27 Oct 2025	Form 3: Paletta George A. Jr., Director Holds 0 shares of Class A Common Stock
01 Oct 2025	Form 3: Powell James Nathaniel, Chief Executive Officer Holds 80,446 shares of Class A Common Stock
21 Apr 2025	Form 3: Blass Devin, CTO & SVP of CMC Holds 121,084 shares of Class A Common Stock
07 Aug 2024	Form 3: Motwani Neha J., Director Holds 0 shares of Class A Common Stock
07 Aug 2024	Form 3: Hajjar Roger Joseph, Director Holds 0 shares of Class A Common Stock
14 May 2024	Form 3: Kender Richard N, Director Holds 0 shares of Class A Common Stock
02 Aug 2023	Form 3: Locklear Lisa, Chief Financial Officer Holds 0 shares of Common Stock
13 Jul 2023	Form 3: Agafonova Nataliya, Chief Medical Officer Holds 0 shares of Common Stock
12 Jun 2023	Form 3: Pfeffer Jeffrey, Director Holds 0 shares of Common Stock
12 Jun 2023	Form 3: Baluch Khoso, Director Holds 0 shares of Common Stock
02 Mar 2023	Form 3: Hashad Mohamed Wa'el Ahmed, Chief Executive Officer Holds 0 shares of Common Stock
06 Apr 2022	Form 3: Min Kwan-Hong Christopher, Chief Medical Officer Holds 0 shares of Common Stock, par value $0.001 per share
22 Feb 2022	Form 3: Girolamo Todd C, Director Holds 0 shares of Common Stock, par value $0.01 per share
07 Jun 2021	Form 3: Ungaro Ursula, Director Holds 0 shares of Common Stock, par value $0.01 per share

Comments